PitchSend

Investor Presentaiton

FY22 Performance Snapshot 3. & گاه FY22 Key Highlights METROPOLIS The Pathology Specialist Revenue Rs. 1,228 Crores +23% YoY Non-Covid Revenue Rs. 1,036 Crores +35% YoY EBITDA (Before CSR, ESOP & one time acquisition cost) Rs. 362 Crores +20% YoY No. of Patients 13.4 Mn +37% YoY EBITDA Margin (Before CSR, ESOP & one time acquisition cost) 29.4% Including Hitech Diagnostics from 22nd Oct, 2021 Blood Tests | Diagnostics | Wellness No. of Tests 25.7 Mn +35% YoY 4

View entire presentation